BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chitneni SK, Zhou Z, Watts BE, Zalutsky MR. Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an 18F-Labeled Analogue of the MDM2 Inhibitor SP-141. Pharmaceuticals (Basel) 2021;14:358. [PMID: 33924734 DOI: 10.3390/ph14040358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Z, Zalutsky MR, Chitneni SK. Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation. Mol Pharm 2021;18:3871-81. [PMID: 34523337 DOI: 10.1021/acs.molpharmaceut.1c00531] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Miles X, Vandevoorde C, Hunter A, Bolcaen J. MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy. Front Oncol 2021;11:703442. [PMID: 34307171 DOI: 10.3389/fonc.2021.703442] [Cited by in F6Publishing: 7] [Reference Citation Analysis]